• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者感染性心内膜炎发病率上升

Increasing Rates of Infective Endocarditis in Patients with Inflammatory Bowel Disease.

作者信息

Shah-Khan Sardar M, Shah-Khan Sardar M, Alqahtani Fahad, Kupec Justin T

机构信息

Department of Internal Medicine, West Virginia University School of Medicine/Ruby Memorial Hospital, Morgantown, USA.

Department of Gastroenterology and Hepatology, West Virginia University School of Medicine/Ruby Memorial Hospital, Morgantown, USA.

出版信息

Cureus. 2020 Feb 8;12(2):e6919. doi: 10.7759/cureus.6919.

DOI:10.7759/cureus.6919
PMID:32190474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7061780/
Abstract

Introduction and aim Infective endocarditis (IE) cases are on the rise in the United States. The incidence of IE in patients with inflammatory bowel disease (IBD) has not been reported. Utilizing a national level database, we sought to estimate the incidence of IE in IBD-related hospitalizations and to determine its outcomes.  Methods Discharge records from the National Inpatient Sample were analyzed, and the International Classification of Diseases, ninth revision, Clinical Modification codes (ICD-9-CM) was used to identify adult patients with IBD (Crohn's disease or ulcerative colitis) and IE between 2003 and 2014. Trends in the incidence of IE were recorded and multivariable regression was used to determine the impact of IE on IBD-hospitalizations. Results The incidence of IE in patients with IBD rose from 14.5 cases per 10,000 admissions in 2003 to 21.7 in 2014. After multivariable adjustment, both patient groups with CD (odds ratio [OR] 3.5, 95% confidence interval [CI] 3.0-4.1) and UC (OR 2.9, 95% CI 2.5-3.5) admitted with IE were found to be at greater risk for in-hospital mortality compared to non-IE admissions. Patients with IBD admitted with IE were found to have greater mean length of stay (13 days vs. six days, p<0.0001) and higher average hospital charges ($36,869.85 vs. $13,324.01, p <0.0001) compared to non-IE admissions.  Conclusions Infective endocarditis is a growing complication in patients with IBD and is associated with increased mortality and utilization of healthcare resources. Further studies addressing the association between IE and IBD are needed.

摘要

引言与目的 在美国,感染性心内膜炎(IE)病例呈上升趋势。炎症性肠病(IBD)患者中IE的发病率尚未见报道。我们利用国家级数据库,旨在估算IBD相关住院患者中IE的发病率,并确定其预后情况。

方法 分析了国家住院患者样本的出院记录,并使用国际疾病分类第九版临床修订本编码(ICD-9-CM)来识别2003年至2014年间患有IBD(克罗恩病或溃疡性结肠炎)和IE的成年患者。记录IE发病率的趋势,并采用多变量回归分析来确定IE对IBD住院患者的影响。

结果 IBD患者中IE的发病率从2003年每10000例入院患者中的14.5例升至2014年的21.7例。经过多变量调整后,与非IE入院患者相比,因IE入院的克罗恩病(CD)患者组(比值比[OR] 3.5,95%置信区间[CI] 3.0 - 4.1)和溃疡性结肠炎(UC)患者组(OR 2.9,95% CI 2.5 - 3.5)的院内死亡风险更高。与非IE入院患者相比,因IE入院的IBD患者平均住院时间更长(13天对6天,p<0.0001),平均住院费用更高(36869.85美元对13324.01美元,p <0.0001)。

结论 感染性心内膜炎是IBD患者中日益增多的并发症,与死亡率增加及医疗资源利用增多相关。需要进一步研究IE与IBD之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/59e82b765bb6/cureus-0012-00000006919-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/9d6fa49ad8ed/cureus-0012-00000006919-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/8ec8957cbeb2/cureus-0012-00000006919-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/ecdbf810e1bd/cureus-0012-00000006919-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/51565e21aefb/cureus-0012-00000006919-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/59e82b765bb6/cureus-0012-00000006919-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/9d6fa49ad8ed/cureus-0012-00000006919-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/8ec8957cbeb2/cureus-0012-00000006919-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/ecdbf810e1bd/cureus-0012-00000006919-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/51565e21aefb/cureus-0012-00000006919-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40b/7061780/59e82b765bb6/cureus-0012-00000006919-i05.jpg

相似文献

1
Increasing Rates of Infective Endocarditis in Patients with Inflammatory Bowel Disease.炎症性肠病患者感染性心内膜炎发病率上升
Cureus. 2020 Feb 8;12(2):e6919. doi: 10.7759/cureus.6919.
2
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.一项关于住院炎症性肠病患者艰难梭菌感染的患病率及影响的全国性调查。
Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29.
3
Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.住院炎症性肠病患者静脉血栓栓塞患病率上升及其对死亡率的影响。
Am J Gastroenterol. 2008 Sep;103(9):2272-80. doi: 10.1111/j.1572-0241.2008.02052.x. Epub 2008 Aug 5.
4
The association of inflammatory bowel disease and immediate postoperative outcomes following lumbar fusion.炎症性肠病与腰椎融合术后即刻手术结局的相关性。
Spine J. 2018 Jul;18(7):1157-1165. doi: 10.1016/j.spinee.2017.11.007. Epub 2017 Nov 15.
5
Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease.炎症性肠病患者的住院费用、住院时长及髋膝关节置换术患病率
World J Gastroenterol. 2017 Jul 14;23(26):4752-4758. doi: 10.3748/wjg.v23.i26.4752.
6
Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.炎症性肠病不会影响急性心肌梗死患者的死亡率,但会增加其住院时间。
Dig Dis Sci. 2021 Dec;66(12):4169-4177. doi: 10.1007/s10620-020-06818-x. Epub 2021 Jan 25.
7
Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study.巴西公共医疗系统中炎症性肠病流行病学的时间趋势:一项基于大量人群的研究。
Lancet Reg Health Am. 2022 Jun 9;13:100298. doi: 10.1016/j.lana.2022.100298. eCollection 2022 Sep.
8
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响:直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.
9
Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.炎症性肠病中肠道感染发病率的上升:一项全国性分析。
Inflamm Bowel Dis. 2018 Jul 12;24(8):1849-1856. doi: 10.1093/ibd/izy086.
10
Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis.公开报告的主动脉瓣手术结果对注射毒品和非注射毒品相关心内膜炎患者瓣膜手术的影响。
Clin Infect Dis. 2020 Jul 27;71(3):480-487. doi: 10.1093/cid/ciz834.

引用本文的文献

1
Infective Endocarditis After Endoscopic Stricture Dilation in Crohn's Disease.克罗恩病内镜下狭窄扩张术后感染性心内膜炎
ACG Case Rep J. 2024 Jun 20;11(6):e01377. doi: 10.14309/crj.0000000000001377. eCollection 2024 Jun.
2
Oral microbiomes of patients with infective endocarditis (IE): a comparative pilot study of IE patients, patients at risk for IE and healthy controls.感染性心内膜炎(IE)患者的口腔微生物群:IE患者、IE风险患者和健康对照的比较性初步研究。
J Oral Microbiol. 2022 Nov 15;15(1):2144614. doi: 10.1080/20002297.2022.2144614. eCollection 2023.

本文引用的文献

1
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.炎症性肠病治疗相关的严重和机会性感染风险。
Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.
2
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.生物疗法与炎症性肠病患者感染和恶性肿瘤风险:系统评价和网络荟萃分析。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1385-1397.e10. doi: 10.1016/j.cgh.2016.04.039. Epub 2016 May 14.
3
Infective Endocarditis Presented as a Right Atrium Mass in a Patient with Ulcerative Colitis.
感染性心内膜炎在一名溃疡性结肠炎患者中表现为右心房肿块。
Case Rep Cardiol. 2015;2015:789170. doi: 10.1155/2015/789170. Epub 2015 May 24.
4
Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.美国 2000 年至 2011 年感染性心内膜炎发病率、微生物学和瓣膜置换的趋势。
J Am Coll Cardiol. 2015 May 19;65(19):2070-6. doi: 10.1016/j.jacc.2015.03.518.
5
Antibiotic prophylaxis for GI endoscopy.胃肠道内镜检查的抗生素预防
Gastrointest Endosc. 2015 Jan;81(1):81-9. doi: 10.1016/j.gie.2014.08.008. Epub 2014 Nov 11.
6
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.欧洲关于炎症性肠病机会性感染预防、诊断和管理的第二项循证共识
J Crohns Colitis. 2014 Jun;8(6):443-68. doi: 10.1016/j.crohns.2013.12.013. Epub 2014 Mar 6.
7
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.英夫利昔单抗联合硫唑嘌呤治疗溃疡性结肠炎优于两药单药治疗。
Gastroenterology. 2014 Feb;146(2):392-400.e3. doi: 10.1053/j.gastro.2013.10.052.
8
Infective endocarditis in the U.S., 1998-2009: a nationwide study.美国 1998-2009 年感染性心内膜炎:一项全国性研究。
PLoS One. 2013;8(3):e60033. doi: 10.1371/journal.pone.0060033. Epub 2013 Mar 20.
9
Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.克罗恩病患者的严重感染和死亡率:TREAT™ 注册研究的 5 年以上随访结果。
Am J Gastroenterol. 2012 Sep;107(9):1409-22. doi: 10.1038/ajg.2012.218. Epub 2012 Aug 14.
10
Society position statement : Canadian Cardiovascular Society/Canadian Anesthesiologists' Society/Canadian Heart Rhythm Society joint position statement on the perioperative management of patients with implanted pacemakers, defibrillators, and neurostimulating devices.学会立场声明:加拿大心血管学会/加拿大麻醉医师学会/加拿大心律协会关于植入式起搏器、除颤器和神经刺激器患者围手术期管理的联合立场声明。
Can J Anaesth. 2012 Apr;59(4):394-407. doi: 10.1007/s12630-012-9678-8.